Hong Kong stock exchange filings show that on August 13, FMR LLC increased its position in AEON Biopharma (00900) by 66,000 shares, priced at HK$9.1708 per share, totaling approximately HK$605,300.
Following the transaction, FMR LLC's latest shareholding stands at around 41.8891 million shares, lifting its ownership ratio to 10.00% of the company.
This move reflects a strategic adjustment by the investment firm, reinforcing its stake in the credit services provider amid ongoing market activities.